DHR · Danaher Corp
Price
Snapshot
50 fields · last close| Market Cap | $156.7B |
| P/E | 39.22 |
| Float | 626.6M |
| Beta | 0.79 |
| Volatility | 19.8% |
| Exchange | NYSE |
| Sector | Life Sciences Tools & Services |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 75.6 |
| Price | 223.41 |
| Change | +0.26% |
| Prev Close | 222.84 |
| Open | 222.25 |
| Day Low | 219.22 |
| Day High | 225.71 |
| Avg Vol | 4 |
| Avg $ Vol | $914.0M |
| 52W High | 242.80 |
| 52W Low | 160.93 |
| 52W Pos | 76.3% |
| From High | −7.99% |
| From Low | +38.82% |
| Max DD 1Y | −33.11% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | +2.09% |
| SMA 50 | +5.34% |
| SMA 200 | +11.10% |
| RSI (14) | 58.2 |
| Vol 30D | 28.8% |
| Vol 90D | 36.0% |
| 1Y Range | 161–243 |
| Daily bars | 534 |
| Perf Week | +3.35% |
| Perf Month | +9.64% |
| Perf Quarter | +10.98% |
| Perf Half Y | +12.47% |
| Perf Year | +8.63% |
| Perf YTD | −3.03% |
| Prev Day | +0.26% |
| Clavix | B |
| Debt / Eq | 0.35 |
| Curr Ratio | 1.87 |
| Int Cover | 13.3× |
| FCF Margin | 21.4% |
| Rev Growth | +2.9% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 7 / 19 |
What DHR does
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions.
The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands.
The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.
Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Clavix risk grade
regraded every trading dayDHR grades B, 75.6 of 100. Steadiest on Macro Resilience (65), most exposed on News Sentiment (55, mixed). 2 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 7 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| DHR | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.79 | 1.17 |
| Volatilityannualized | 19.8% | 29.3% |
| Max drawdown, past yearworst peak-to-trough fall | −33.1% | — |
| Typical daily movemedian absolute daily change | 1.01% | — |
| Days beyond ±3%of the last 252 sessions | 21 (8%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| DHR | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.79 | 1.17 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 47% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| DHR | |
|---|---|
| 1 week | +3.4% |
| 1 month | +9.6% |
| Year to date | −3.0% |
| 1 year | +8.6% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| DHR | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 23 Jul |
| Average score0 most bearish, 100 most bullish | 58 |
| Bullish · bearisharticles above 60 · below 40 | 19 · 4 |
| Directionarticles whose tone is improving vs worsening | 19 ↑ 4 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| DHR | |
|---|---|
| Revenue growthyear over year | +2.9% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openDanaher announced a collaboration with NVIDIA to advance autonomous science by combining Danaher's scientific instruments, lab automation, and workflow software with NVIDIA's AI and accelerated computing. The partnership was announced on October 14, 2026.
Danaher announced the appointment of Daniel L. Comas and Robert Hershberg, M.D. to its Board of Directors on October 12, 2026. The article body is very short and provides no further details about their roles or backgrounds.
Sell-side analysts covering Danaher (DHR) have a consensus rating of 'Moderate Buy,' based on 23 analysts: four with hold ratings, seventeen with buy ratings, and two with stronger buy ratings.
Danaher announced plans to launch its first AI-powered autonomous lab, combining artificial intelligence, robotics, and technologies from several of its operating companies to help researchers develop custom antibodies and other molecular tools. The lab is expected to operate at scale in early 2027, and the company says it could speed research from discovery to breakthrough by up to 8x.
Danaher shares fell about 3.9% intraday (closing down 4.5% at $211.71) after the company officially installed Julie Sawyer Montgomery as its new president and CEO, replacing Rainer Blair as part of a succession plan first announced in August 2026. Blair will stay on as a senior advisor through March 2027 to help with the transition.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | B+ | $245.2B | 35.15 | 0.86 | Compare |
| A | Agilent Technologies Inc | B | $48.38B | 33.59 | 1.25 | Compare |
| IQV | IQVIA Holdings Inc | B | $42.91B | 31.30 | 1.17 | Compare |
| WAT | Waters Corp | B+ | $42.45B | 255.53 | 1.16 | Compare |
| ILMN | Illumina Inc | B- | $40.95B | 50.16 | 1.43 | Compare |
| MTD | Mettler-toledo International Inc | B+ | $32.02B | 34.92 | 1.20 | Compare |
| WST | West Pharmaceutical Services Inc | A- | $23.90B | 48.13 | 1.15 | Compare |
| RVTY | Revvity Inc | B | $17.30B | 73.02 | 1.09 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.